These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 24548403)
1. [Study of the expression and function of Syk and VEGF-C in the development of non-small cell lung cancer]. Guo JZ; Sun QF; Cong B; Zhao YP; Peng CL; Zhao XG Zhonghua Yi Xue Za Zhi; 2013 Dec; 93(47):3801-3. PubMed ID: 24548403 [TBL] [Abstract][Full Text] [Related]
2. [Regulatory role of Syk gene on vascular endothelial growth factor C expression in breast cancer]. Chen XL; Li L; Zhang YJ Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):805-9. PubMed ID: 22336204 [TBL] [Abstract][Full Text] [Related]
3. Involvement of syk and VEGF-C in invasion of lung adenocarcinoma A549 cells. Sun Q; Peng C; Cong B; Hao Y; Guo J; Zhao Y; Zhao X J Cancer Res Ther; 2016; 12(2):640-4. PubMed ID: 27461624 [TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of syk transfection on lung cancer cell invasion. Peng CL; Zhang Y; Sun QF; Zhao YP; Hao YT; Zhao XG; Cong B Asian Pac J Cancer Prev; 2013; 14(5):3001-3. PubMed ID: 23803069 [TBL] [Abstract][Full Text] [Related]
5. [Inhibitory effect of full-length spleen tyrosine kinase on invasion and metastasis of human laryngeal squamous cells]. Li Z; Cai Z; Tao B; Jin Q Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Nov; 49(11):943-9. PubMed ID: 25598376 [TBL] [Abstract][Full Text] [Related]
6. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways. Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174 [TBL] [Abstract][Full Text] [Related]
7. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer. Takizawa H; Kondo K; Fujino H; Kenzaki K; Miyoshi T; Sakiyama S; Tangoku A Br J Cancer; 2006 Jul; 95(1):75-9. PubMed ID: 16755294 [TBL] [Abstract][Full Text] [Related]
8. [Expression of vascular endothelial growth factor (VEGF) C and VEGF receptor 3 in non-small cell lung cancer]. Dong X; Qiu XS; Wang EH; Li QC; Gu W Zhonghua Bing Li Xue Za Zhi; 2003 Apr; 32(2):128-32. PubMed ID: 12839674 [TBL] [Abstract][Full Text] [Related]
9. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C. Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183 [TBL] [Abstract][Full Text] [Related]
10. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments]. Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094 [TBL] [Abstract][Full Text] [Related]
11. [Construction of the eukaryotic expression vector of human syk and its effect on MHC-I expression of human breast cancer cells]. Shan BE; Song XT; Qi YX Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jan; 24(1):3-5. PubMed ID: 18177606 [TBL] [Abstract][Full Text] [Related]
12. The relationship between methylation of the Syk gene in the promoter region and the genesis of lung cancer. Ma L; Dong S; Zhang P; Xu N; Yan H; Liu H; Li Y; Zhou Q Clin Lab; 2010; 56(9-10):407-16. PubMed ID: 21086786 [TBL] [Abstract][Full Text] [Related]
13. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma. Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370 [TBL] [Abstract][Full Text] [Related]
14. Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer. Feng Y; Wang W; Hu J; Ma J; Zhang Y; Zhang J Anat Rec (Hoboken); 2010 May; 293(5):802-12. PubMed ID: 20225197 [TBL] [Abstract][Full Text] [Related]
15. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma]. Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440 [TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node. Saintigny P; Kambouchner M; Ly M; Gomes N; Sainte-Catherine O; Vassy R; Czernichow S; Letoumelin P; Breau JL; Bernaudin JF; Kraemer M Lung Cancer; 2007 Nov; 58(2):205-13. PubMed ID: 17686546 [TBL] [Abstract][Full Text] [Related]
17. Syk tyrosine kinase is linked to cell motility and progression in squamous cell carcinomas of the head and neck. Luangdilok S; Box C; Patterson L; Court W; Harrington K; Pitkin L; Rhŷs-Evans P; O-charoenrat P; Eccles S Cancer Res; 2007 Aug; 67(16):7907-16. PubMed ID: 17699797 [TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin-like transcript 4 promotes tumor progression and metastasis and up-regulates VEGF-C expression via ERK signaling pathway in non-small cell lung cancer. Zhang P; Guo X; Li J; Yu S; Wang L; Jiang G; Yang D; Wei Z; Zhang N; Liu J; Sun Y Oncotarget; 2015 May; 6(15):13550-63. PubMed ID: 25948790 [TBL] [Abstract][Full Text] [Related]
19. (-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α. He L; Zhang E; Shi J; Li X; Zhou K; Zhang Q; Le AD; Tang X Cancer Chemother Pharmacol; 2013 Mar; 71(3):713-25. PubMed ID: 23292117 [TBL] [Abstract][Full Text] [Related]
20. Effect of spleen tyrosine kinase on nonsmall cell lung cancer. Hao YT; Peng CL; Zhao YP; Sun QF; Zhao XG; Cong B J Cancer Res Ther; 2018; 14(Supplement):S100-S104. PubMed ID: 29578158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]